Objective: The objective of the present study was to formulate sustained release glipizide loaded microspheres and evaluate the effect of various variables on their properties. Materials and Methods: The microspheres were prepared by non solvent addition coacervation method. Ethyl cellulose used as a polymer, petroleum ether (60-40º) for induced coacervation and n-hexane as non solvent for microspheres preperation. Results: Microspheres were characterized in term of percent yield, percent entrapment and release pattern of drug. The shape, color and particle size of microspheres were also evaluated. According the result of formulation, n-hexane used as non solvent resulted in enhances rigidization of coating and petroleum ether (60-40º) for ...
This article illustrates the Formulation and Characterization of Mucoadhesive microspheres of Glicla...
This article illustrates the Formulation and Characterization of Mucoadhesive microspheres of Glicla...
Repaglinide is a potent second generation oral hypoglycaemic agent widely used in treatment of non ...
Objective: The purpose of this research was to formulate and evaluate floating microsphere of glipiz...
Purpose: The purpose of the present investigation was to formulate and evaluate microencapsulated gl...
Purpose: The purpose of the present investigation was to formulate and evaluate microencapsulated gl...
Objective: The present work is aimed to formulate and evaluate alginate-chitosan microspheres of gli...
Glipizide is a potent, rapid-acting with short duration of action and well tolerated second-generati...
Purpose: The purpose of the present investigation was to formulate and evaluate microencapsulated g...
Objective: The aim of the present study was to formulate a microemulsion for the oral delivery of Gl...
Recently, several technical advancements have led to the development of several novel drug delivery ...
Recently, several technical advancements have led to the development of several novel drug delivery ...
This article illustrates the Formulation and Characterization of Mucoadhesive microspheres of Glicla...
The aim of this study was to formulate gliclazide loaded controlled release microspheres. Microspher...
This article illustrates the Formulation and Characterization of Mucoadhesive microspheres of Glicla...
This article illustrates the Formulation and Characterization of Mucoadhesive microspheres of Glicla...
This article illustrates the Formulation and Characterization of Mucoadhesive microspheres of Glicla...
Repaglinide is a potent second generation oral hypoglycaemic agent widely used in treatment of non ...
Objective: The purpose of this research was to formulate and evaluate floating microsphere of glipiz...
Purpose: The purpose of the present investigation was to formulate and evaluate microencapsulated gl...
Purpose: The purpose of the present investigation was to formulate and evaluate microencapsulated gl...
Objective: The present work is aimed to formulate and evaluate alginate-chitosan microspheres of gli...
Glipizide is a potent, rapid-acting with short duration of action and well tolerated second-generati...
Purpose: The purpose of the present investigation was to formulate and evaluate microencapsulated g...
Objective: The aim of the present study was to formulate a microemulsion for the oral delivery of Gl...
Recently, several technical advancements have led to the development of several novel drug delivery ...
Recently, several technical advancements have led to the development of several novel drug delivery ...
This article illustrates the Formulation and Characterization of Mucoadhesive microspheres of Glicla...
The aim of this study was to formulate gliclazide loaded controlled release microspheres. Microspher...
This article illustrates the Formulation and Characterization of Mucoadhesive microspheres of Glicla...
This article illustrates the Formulation and Characterization of Mucoadhesive microspheres of Glicla...
This article illustrates the Formulation and Characterization of Mucoadhesive microspheres of Glicla...
Repaglinide is a potent second generation oral hypoglycaemic agent widely used in treatment of non ...